SEC Form 4 · accession 0000920465-15-000084
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura L. Douglass
Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $28.24 | Dec 21, 2015 | A | 10,000 | A | Dec 21, 2016 | Dec 21, 2025 | Common Stock | 10,000 | 10,000 | D |